Prescriber's Corner
Denosumab vs. Denosumab: One Drug, Two Products, and Two Different Indications
Vivian Tsang, PharmD, BCOP, and Jennifer Kwon, PharmD
From Cedars-Sinai Medical Center, Los Angeles, California
The authors have no conflicts of interest to disclose.
Correspondence to: Vivian Tsang, PharmD, BCOP, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048. E-mail: tsangv@cshs.org
J Adv Pract Oncol 2011;2:278–281 |
DOI: 10.6004/jadpro.2011.2.4.8 |
© 2011 Harborside Press®
For access to the full length article, please
sign in.
